Last reviewed · How we verify
NCT04525196
Physical Activity in Dialysis: Clinical and Biological Impact
NA trial testing Physical activity. in Chronic Renal Failure in 250 participants. Status unknown.
29 July 2025
Quick facts
| Lead sponsor | Elsan |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 250 |
| Start date | 29 January 2021 |
| Primary completion | 29 July 2025 |
| Estimated completion | 29 July 2025 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Physical activity.
Conditions studied
- Chronic Renal Failure — all drugs for Chronic Renal Failure →
Sponsor
Elsan — full company profile →
Who can join
18 and older, any sex, with Chronic Renal Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical inactivity is known to increase the risk of developing many diseases as cardiovascular diseases, diabetes, some cancers, and other chronic diseases. The impact of the inactivity is even higher in a fragile population as patients with Chronic Renal Failure (CRF) who need dialysis. This can lead to serious adverse events during the lifetime of these patients, such as arteriopathy which can result in amputation, deterioration of general condition, loss of independence and depression of wasting away. Despite the need to promote physical activity in this population of hemodialysis patients with CRF, little is known about the effects of a supervised physical activity conducted in these patients. With this study, the investigators propose to assess the effects of a physical activity program on several parameters, in hemodialysis subjects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Current State of the Art and Science of Exercise in Dialysis: A Narrative Review.
Borkum M, Levin A, Ficocelli J, Wone L, et al · · 2024 · cited 1× · PMID 38370309 · DOI 10.1177/20543581241229253
Verify or expand the search:
- PubMed search for NCT04525196
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Renal Failure
Currently open trials in the same condition.
- NCT06227468 — A Clinical Study to Map the HLA Genomic Region in the Greek Population · recruiting
- NCT06347029 — Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure P · NA · recruiting
- NCT05884866 — A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to B · Phase 2 · recruiting
- NCT05353946 — Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure · NA · recruiting
Other Elsan trials
Trials by the same sponsor.
- NCT07464665 — Comparing Dual-mobility Cups Versus Unipolar Cups for Unselected Primary Total Hip Arthroplasty by Direct Anterior Appro · NA · not yet recruiting
- NCT07267572 — Evaluation of the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer · NA · not yet recruiting
- NCT07248124 — Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse · NA · recruiting
- NCT06835790 — Comparative 3-year Study of Nissen-sleeve vs. Sleeve Plus Cruroplasty in Obese Patients With Hiatal Hernia · NA · not yet recruiting
- NCT06822452 — Prospective Comparative Study Evaluating the Early Complications of Robot-assisted Radical Prostatectomy Performed as an · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04525196 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Elsan
- Last refreshed: 19 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04525196.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing